A novel homozygous MMP2 mutation in a family with Winchester syndrome
- PMID: 16542393
- DOI: 10.1111/j.1399-0004.2006.00584.x
A novel homozygous MMP2 mutation in a family with Winchester syndrome
Abstract
The 2001 International Classification of Constitutional Disorders of Bone has included in the group of multicentric hands and feet osteolysis syndromes three autosomal recessive inherited disorders: Winchester, Torg and nodulosis-arthropathy-osteolysis (NAO) syndromes. Nosographic delineations of these rare syndromes are difficult to define, and there is no consensus. In 2001, two mutations in the matrix metalloproteinase 2 gene (MMP2) have been identified in two families with a NAO phenotype. In a recent study, a homozygous MMP2 mutation has also been identified in a patient presenting with Winchester syndrome. We report the clinical evolution of two sisters with a Winchester phenotype. Clinical review over 23 years provides information on the general evolution of osteolysis and points to an intrafamilial variation with clinical and radiological changes during the patients' life. In both sisters, we identified a new homozygous mutation in the catalytic domain of the MMP2 gene. Our study results are consistent with the involvement of MMP2 in Winchester syndrome and with the hypothesis that Winchester and NAO syndromes are allelic disorders that form a continuous clinical spectrum. At last, our observation emphasizes the interest of molecular analysis in genetic counselling of this consanguineous family.
Similar articles
-
Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2.Clin Genet. 2005 Mar;67(3):261-6. doi: 10.1111/j.1399-0004.2004.00402.x. Clin Genet. 2005. PMID: 15691365
-
Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome.J Bone Miner Res. 2007 Feb;22(2):329-33. doi: 10.1359/jbmr.061013. J Bone Miner Res. 2007. PMID: 17059372
-
Absence of MMP2 mutation in idiopathic multicentric osteolysis with nephropathy.Clin Orthop Relat Res. 2007 Sep;462:80-6. doi: 10.1097/BLO.0b013e3180d09db8. Clin Orthop Relat Res. 2007. PMID: 17563705
-
Patient with mutation in the matrix metalloproteinase 2 (MMP2) gene - a case report and review of the literature.J Clin Res Pediatr Endocrinol. 2014;6(1):40-6. doi: 10.4274/Jcrpe.1166. J Clin Res Pediatr Endocrinol. 2014. PMID: 24637309 Free PMC article. Review.
-
Multicentric osteolytic syndromes represent a phenotypic spectrum defined by defective collagen remodeling.Am J Med Genet A. 2019 Aug;179(8):1652-1664. doi: 10.1002/ajmg.a.61264. Epub 2019 Jun 19. Am J Med Genet A. 2019. PMID: 31218820 Review.
Cited by
-
Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.Dev Dyn. 2007 Jun;236(6):1683-93. doi: 10.1002/dvdy.21159. Dev Dyn. 2007. PMID: 17440987 Free PMC article.
-
Matrix Metallopeptidase 2 Gene Polymorphism is Associated with Obesity in Korean Population.Korean J Physiol Pharmacol. 2008 Jun;12(3):125-9. doi: 10.4196/kjpp.2008.12.3.125. Epub 2008 Jun 30. Korean J Physiol Pharmacol. 2008. PMID: 20157405 Free PMC article.
-
Allele-specific aberration of imprinted domain chromosome architecture associates with large offspring syndrome.iScience. 2022 Apr 20;25(5):104269. doi: 10.1016/j.isci.2022.104269. eCollection 2022 May 20. iScience. 2022. PMID: 35542046 Free PMC article.
-
A framework for application of metabolic modeling in yeast to predict the effects of nsSNV in human orthologs.Biol Direct. 2014 Jun 3;9:9. doi: 10.1186/1745-6150-9-9. Biol Direct. 2014. PMID: 24894379 Free PMC article.
-
Destroy to Rebuild: The Connection Between Bone Tissue Remodeling and Matrix Metalloproteinases.Front Physiol. 2020 Feb 5;11:47. doi: 10.3389/fphys.2020.00047. eCollection 2020. Front Physiol. 2020. PMID: 32116759 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous